Reich Samuel J has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 4800000 shares of SAB Biotherapeutics, Inc. ($SABS) on February 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | SAB Biotherapeutics, Inc. | $SABS | Reich Samuel J | CEO | A | Stock option (right to buy) | 4800000 | $0.00 | 4,800,000.0000 | 77,863,263 | 9999.99% | 6.16% |
| Aug. 26, 2025 | SAB Biotherapeutics, Inc. | $SABS | Reich Samuel J | CEO & EXECUTIVE CHAIRMAN | A | Stock Option (right to buy) | 4800000 | $0.00 | 4,800,000.0000 | 9,261,918 | 9999.99% | 51.83% |
| July 15, 2024 | SAB Biotherapeutics, Inc. | $SABS | Reich Samuel J | CEO & EXECUTIVE CHAIRMAN | A | Stock Option (right to buy) | 35700 | $0.00 | 35,700.0000 | 5,521,487 | 9999.99% | 0.65% |
| Feb. 21, 2024 | SAB Biotherapeutics, Inc. | $SABS | Reich Samuel J | CEO & EXECUTIVE CHAIRMAN | A | Employee Stock Option (right to buy) | 434000 | $0.00 | 434,000.0000 | 5,521,487 | 9999.99% | 7.86% |